“…Ghanbari et al., 2020 [ 67 ] Observational, retrospective, single center | Total: 876 | SDD: 29% | NSTE-ACS, lesion type A, B1, B2, C | Denmark | ND | None | MACE: death, stroke, MI, revascularization, vascular complications, CABG, rehospitalization, bleeding | 30-day MACE: SDD 1.5% vs. OS 1.4% | SDD: 190 | OS: 21% | OS: 91% of early adverse events within 9 h postprocedure |
OS: 686 |
13. Gokhale et al., 2020 [ 68 ] | Retrospective, single center | Total: 496 | SDD: 100% | Elective PCI, single vessel, bifurcation, RA | USA | ND | None | Primary: MACE (death, MI, stroke), TVR at 30 days | 30-day MACE: SDD 0% vs. OS 1.3% ( p = 0.5) |
SDD: 76 | OS: 100% | Secondary: unscheduled medical contact |
OS: 138 |
14. Liew et al., 2020 [ 20 ] | Observational, prospective, multicenter | SDD: 586 | SDD: 67.1% | Elective PCI, complex (47.6%), MV (5.6%), LM (0.5%) | Australia | ND | ND | 30-day MACCE (death, MI, TLR, major bleeding), average costs | 30-day MACCE: 0.7% SDD vs. 1.7% OS ( p = 0.253), 30-day rehospitalization: 0.7% SDD vs. 1.8% OS ( p = 0.159) |
OS: 17,515 | OS: 45.5% | Favorable patient perception |
15. |
…”